United States · Platforms & data · Stocktwits

ImmunityBio Treats First Patients In Europe With Anktiva Plus BCG – Retail Calls It A ‘Great Opening Act’ For Q3 Earnings

Published by Stocktwits · United States 9 h ago

ImmunityBio said Accord Healthcare will provide commercial expertise and market access support for Anktiva in Europe.

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

The Motley Fool

Why Palantir Technologies Stock Dropped Today

Fairfax Financial (OTCMKTS:FRFHF) Hits New 1-Year High After Strong Earnings

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030